SKELETAL MUSCLE HAS A REMARKABLE ABILITY to adapt to changes in response to metabolic demands. For example, chronic contractile activity (CCA) increases the oxidative capacity of muscle through the induction of mitochondrial biogenesis. This process is complex because the expansion of the mitochondrial network requires the cooperation of both the nuclear and mitochondrial genomes. Mitochondria contain double-stranded circular DNA that encodes less than 1% of the proteins necessary for the electron transport chain and organelle function (9, 40) . Thus, mitochondrial biogenesis is highly dependent on the expression of proteins encoded by nuclear DNA to ensure the proper assembly and expansion of the mitochondrial reticulum (16) . Although the increase in mitochondrial content with chronic exercise has been well established, the important nuclear regulatory proteins involved remain to be fully elucidated.
Peroxisome proliferator-activated receptor (PPAR)␥ coactivator-1␣ (PGC-1␣) has been deemed a dominant regulator of mitochondrial content and is critical to organelle function, respiration, and biogenesis in skeletal muscle (1, 35, 39) . PGC-1␣ is a potent activator of organelle biogenesis via its ability to enhance the activity of numerous nuclear transcription factors, such as nuclear respiratory factor (NRF)-1/2 and estrogen-related receptor-␣ (ERR␣), which control the expression of nuclear genes encoding mitochondrial proteins (NUGEMPs) (31) . Evidence also suggests that PGC-1␣ may be an important mediator of mitochondrial biogenesis that occurs in response to CCA. The basis for a role of PGC-1␣ in exercise-induced mitochondrial adaptations originated from studies that demonstrated increases in PGC-1␣ mRNA and protein levels along with the concurrent upregulated expression of NUGEMPs and markers of mitochondrial content such as cytochrome c oxidase (COX) activity (7, 12, 17, 32) . Further evidence has also been provided from PGC-1␣ transgenic animals. Muscle-specific overexpression of PGC-1␣ influences muscle phenotype, resulting in alterations of muscle composition associated with enhanced oxidative capacity (30) . Muscles from these animals also display a greater resistance to fatigue along with increased expression of genes encoding proteins involved in oxidative metabolism, such as cytochrome c (6, 30) . In contrast, animals lacking PGC-1␣ are exercise intolerant and have reduced expression of key mitochondrial proteins (1, 13) .
Although these results illustrate PGC-1␣ to be an important nuclear regulatory protein involved in exercise-induced adaptations, Leick et al. (26) have suggested that PGC-1␣ is not mandatory for training-evoked mitochondrial biogenesis, since whole body PGC-1␣-knockout (KO) animals are able to adapt to an exercise program in a manner similar to wild-type animals. In contrast, other studies using animals with a musclespecific deletion of PGC-1␣ have documented attenuated exercise-induced increases in mitochondrial proteins, such as cytochrome c and COX-IV (10) , and that the p38␥ MAPKdependent increase in PGC-1␣ is required for endurance exercise-induced mitochondrial biogenesis (33) . Thus, the role of PGC-1␣ in mediating exercise-induced increases in mitochondrial content is controversial. To help resolve this issue, we employed a cell culture approach. This unique in vitro skeletal muscle contractile activity system affords us the ability to induce large changes in mitochondrial biogenesis in muscle cells within a short period of time, which are solely dependent on the contractile activity of the cells, independent of whole body or neural influences that may impact the outcome of in vivo studies. To assess the role of PGC-1␣, we induced mitochondrial biogenesis in the presence of siRNA-induced PGC-1␣ depletion. This allowed us to investigate the importance of PGC-1␣ in the more physiological context of reduced, rather than absent, levels of the coactivator, as found in KO models. Furthermore, unlike previous studies, we sought to assess the activation of kinases as well as the expression of alternative coregulatory proteins (i.e., PGC-1 family members) and transcription factors (e.g., NRF-1/2) to identify any potential compensatory alterations in response to impaired PGC-1␣ levels in the presence of contractile activity. We hypothesized that the knockdown of PGC-1␣ would reveal the coactivator to be an important regulator of CCA-evoked mitochondrial biogenesis despite alterations in compensatory proteins and signaling kinase activity.
METHODS
Cell culture. C2C12 murine skeletal muscle cells were proliferated on six-well culture dishes (Sarstedt, Montreal, QC, Canada) coated with 0.1% gelatin in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillinstreptomycin (P/S). At 90 -95% confluency, differentiation into myotubes was induced by switching the medium to DMEM supplemented with 5% heat-inactivated horse serum (HS) and 1% P/S.
Stimulation of muscle cells to induce CCA. Lids from plastic six-well dishes (3.5-mm wells) were fitted with two platinum wire electrodes such that 2-cm lengths ran parallel to each other at opposite ends of the dish ϳ2 cm apart. Myotubes were subjected to electrical stimulation-induced contractile activity in a parallel circuit (4 six-well dishes at a time/protocol) at a frequency of 5 Hz and an intensity of 9 V chronically for 3 h/day over 4 successive days beginning on day 5 of differentiation, as described previously (7, 17, 18) . Differentiation medium (2 ml) was replenished 1 h prior to stimulation. Following this time, custom-made lids with implanted electrodes replaced typical lids, and dishes were attached to the electrical stimulator unit. Each well was carefully inspected to ensure electrodes were submerged in the medium prior to the stimulation. Myotubes were quiescent for 21 h after each bout of contractile activity, and the medium was changed 1 h prior to stimulation each day. The total stimulation protocol lasts for 4 days, and cells were collected for enzyme, protein, or RNA extractions 21 h after the fourth stimulation period. We define this treatment CCA in this cell culture model to differentiate it from the responses observed under more acute stimulation conditions. These would consist of a single bout of contractile activity lasting for minutes or up to a few hours, followed immediately by cellular extraction in the absence of a recovery period.
Transfection experiments. Custom-made PGC-1␣ Stealth small interfering RNA (siRNA; 5=-UUUCUGGGUGGAUUGAAGUG-GUGUA-3=) and scrambled control oligonucleotides (5=-UUUGGUGGGUAGUAAUGGGUUCGUA-3=) were purchased from Invitrogen. For knockdown of PGC-1␣, C 2C12 cells were differentiated as described previously, and the medium was switched to pretransfection medium (DMEM and 10% FBS) on day 4 of differentiation. The following day, myotubes were incubated with 160 nM of scrambled or PGC-1␣-specific siRNA and 10 l of Lipofectamine 2000 for 6 h in 2 ml of DMEM. The medium was then changed back to DMEM supplemented with 5% HS and 1% P/S, and cells either were subjected to CCA or remained under control conditions. Transfection efficiency was assessed with the use of BLOCK-IT Fluorescent siRNA probes (Invitrogen), following the same protocol described above. Images taken immediately after the 6 h of transfection or 24 and 48 h posttransfection all reveal ϳ90% transfection efficiency (data not shown). A subset of cells was transfected with an adenovirus carrying the mouse PGC-1␣ coding region along with an HA tag, which was developed using the AdEasy Adenoviral Vector System (Agilent Technologies) according to the manufacturer's instructions. Myotubes transduced at a multiplicity of infection of 100 displayed 99% infection efficiency (data not shown). On day 4 of differentiation, C 2C12 myotubes were infected with the PGC-1␣-HA tag adenovirus for 24 h. The following day, myotubes were transfected with either the scrambled or PGC-1␣ siRNA, as described above. Cells were collected, and protein extracts were made 5 days post-siRNA transfection.
COX activity. Cells were harvested 21 h after the last stimulation period and resuspended in 120 l of enzyme extraction buffer (100 mM Na-K-phosphate, 2 mM EDTA, pH 7.2), sonicated 3 ϫ 3 s on ice, and subjected to repeated freeze-thaw cycles. The supernate was removed and used to measure COX enzyme activity. The rate of COX was measured over time as a reduction in absorbance at 550 nm. COX activity was examined using a 96-well plate in the Synergy HT microplate reader at 30°C, and the data were compiled using KC4 software. Protein concentration was determined using the Bradford assay, and COX activity was adjusted for total protein content.
Cellular respiration. Control and CCA-treated cells were briefly washed and harvested from six-well dishes 21 h after the 4th day of stimulation. Myotubes were resuspended in prewarmed PBS, and oxygen consumption was measured using a Clarke oxygen electrode at 30°C, as described previously (22) . Under these conditions, oxygen consumption is reliant on the provision of endogenous substrates within the cells. All measurements were normalized to total cellular protein content.
Immunoblotting. Protein extracts from myotubes were separated on 8 -12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes using a semidry electrotransfer apparatus. The membranes were blocked for 1 h with 5% skim milk in 1ϫ TBST [Tris-buffered saline-Tween-20, 25 mM Tris·HCl (pH 7.5), 1 mM NaCl, and 0. , total p38 (1:1,000), PGC-1␣ (1:500), HA tag (1:500), and ␣-tubulin (1:8,000) overnight at 4°C. The next day, blots were washed (3 ϫ 5 min) using 1ϫ TBST and incubated with the corresponding secondary antibodies for 1 h at room temperature. Membranes were developed with Western Blot Luminol Reagent (Santa Cruz Biotechnology), and films were scanned and analyzed using SigmaScan Pro (version 5) software. The quantification of all blots was corrected for loading using ␣-tubulin. Antibodies were obtained from Calbiochem (␣-tubulin, CP06), Invitrogen (COX-IV, A21348), Stressgen (mtHSP70, SPS-825), Cell Signaling Technology (p-AMPK, 2531S; t-AMPK, 2532; p-p38, 9211S; t-p38, 9212), Millipore (PGC-1␣, AB3242; p-ACC, 07-303), and Covance (HA tag, MMS-101R), and the cytochrome c antibody was produced in our laboratory. The Tfam and TFB1M antibodies were generous gifts from Dr. Hiroshi Inagaki (11) and Dr. Anna Trifunovic (Karolinska Institute), respectively.
RNA isolation and RT-PCR analyses. RNA was isolated from C2C12 muscle cells as described previously (7) with TRIzol reagent and resuspended in ϳ25 l of sterile water. Total RNA concentration and purity were assessed using the absorbance readings at 260 and 280 nm. RT was performed using Superscript II Reverse Transcriptase (Invitrogen) according to the instructions from the manufacturer, and PCRs were conducted using the primers displayed in Table 1 . PCR products were analyzed on ethidium bromide-stained agarose gels, and expected size products were quantified using SigmaScan Pro (version 5) software. The quantification of all target genes was corrected using the internal control ␤-actin.
Fluorescence microscopy of muscle cells. C2C12 muscle cells were grown and differentiated on custom-made glass-bottom six-well dishes. Following 4 days of CCA, control and siRNA-transfected cells were treated with 100 nM MitoTracker Green FM (M7514; Molecular Probes) and incubated at 37°C for 45 min. Following incubation, cells were washed with PBS, and medium was switched to differentiation medium. Mitotracker Green is a probe that is selective for mitochondria and allows for labeling and identification of the organelles. Fluorescence was visualized using the Nikon Eclipse TE2000-U microscope, and all images were taken at the same exposure. The images presented are representative of ϳ35 images of each condition and were selected in a blinded fashion.
ATP measurements. Extractions and measurements of ATP concentrations were performed as described previously (19) . Cells were washed in cold 1ϫ PBS and collected in microcentrifuge vials following treatments. A 100-l aliquot from each sample was saved to normalize ATP levels to total protein concentrations. The remaining cells were centrifuged for 1 min at 14,000 g. Each fraction was resuspended in 80 l of 1ϫ PBS along with 10 l of cold 70% HClO 4. Samples were then rigorously vortexed and incubated on ice for 10 min. Following a 5-min spin (14,000 g) at 4°C, 110 l of cold 2 M KOH was added to the supernate, which was then mixed, incubated on ice (3 min), and then centrifuged at 14,000 g. Extracts were stored at Ϫ80°C until use. ATP levels were measured using a Lumat LB9507 luminometer. ATP measurements were made in tubes containing lysis buffer and luciferase-luciferin (Promega). After 10 min of incubation, 5 l of sample was added, and ATP concentrations were determined relative to ATP standards.
Statistical analyses. The data are expressed as a fraction of the respective control, nonstimulated, nonknockdown condition. This represents the fold change relative to the control condition for a given experiment (excluding the results collected for COX activity and cellular respiration, which are shown in absolute units). All graphs were constructed using the means Ϯ SE of these values. Student's t-tests were used for comparison of data between control and CCA myotubes. Two-way analyses of variance were performed when control and CCA conditions were being compared between scrambled and siRNA-transfected cells, followed by Bonferroni post hoc tests when appropriate. Statistical differences were considered significant if P Ͻ 0.05.
RESULTS

CCA-induced changes in markers of mitochondrial content.
To assess alterations in mitochondrial content in response to contractile activity, various markers of organelle biogenesis were examined. Muscle cells subjected to 4 days of contractile activity displayed a significant increase in COX enzyme activity (Fig. 1A) , indicative of an increase in mitochondrial content. Whole cell oxygen consumption was also elevated 2.9-fold in myotubes 21 h following the last bout of 4 days of contractile activity (P Ͻ 0.05; Fig. 1B ). This increase has been shown to be proportional to changes in mitochondrial DNA (mtDNA) content (37), a change we have noted previously (22) . Nuclear-encoded proteins critical to mitochondrial biogenesis were concurrently upregulated with contractile activity. Mitochondrial transcription factor A (Tfam) and COX-IV protein levels were 2.3-and 3.9-fold greater, respectively, in muscle cells subjected to CCA relative to control (P Ͻ 0.05; Fig. 1C ). The expression of mitochondrial heat shock protein 70 (mtHSP70), a component of the protein import machinery, was also elevated 3.1-fold as a result of contractile activity (P Ͻ 0.05; Fig. 1C ). 
PGC-1␣ and -␤, peroxisome proliferator-activated receptor-␥ coactivator-1␣ and -␤, respectively; PRC, PGC-1␣-related coactivator; RIP140, receptorinteracting protein 140 kDa; NRF-1 and -2, nuclear respiratory factor-1 and 2, respectively; ERR␣, estrogren-related receptor-␣; COX-I, cytochrome c oxidase I. The primers were constructed against the murine nucleotide sequence for each specified gene. Fig. 1 . Chronic contractile activity (CCA)-induced changes in markers of mitochondrial biogenesis. Cytochrome c oxidase (COX) enzyme activity (n ϭ 7; A) and oxygen consumption (n ϭ 9; B) in skeletal muscle cells subjected to 4 days of CCA relative to control cells (*P Ͻ 0.05 vs. control). C: protein expression of nuclear-encoded mitochondrial proteins mitochrondrial transcription factor A (Tfam; n ϭ 3), COX-IV (n ϭ 4), and mitochondrial heat shock protein 70 (mtHSP70; n ϭ 6) as a result of CCA. Representative Western blots are shown with graphic quantification expressed as a fraction of control (Con) cells (*P Ͻ 0.05 vs. control).
PGC-1␣ knockdown and its effects on potential compensatory coregulatory proteins.
Skeletal muscle cells transfected with siRNA targeted to PGC-1␣ exhibited a reduced mRNA level of the coactivator by ϳ60% on both day 7 and day 9 of differentiation (P Ͻ 0.05; Fig. 2A ). Increasing the transfected dose of siRNA did not further reduce PGC-1␣ mRNA levels (data not shown). Since PGC-1␣ is one of three proteins that comprise the family of PGC-1 transcriptional coactivators, the other homologs PGC-1␤ and PGC-1␣-related coactivator (PRC) were examined to determine any compensatory changes that might be evident with impaired levels of PGC-1␣. PGC-1␤ and PRC mRNA levels remained unaltered in response to reduced PGC-1␣ (Fig. 2B) . In addition, mRNA expression of the PGC-1␣ antagonist receptor-interacting protein 140 kDa (RIP140) was also unaltered in PGC-1␣ siRNAtransfected compared with control cells (Fig. 2B) .
Effect of PGC-1␣ knockdown on the expression of NUGEMPs. We assessed whether PGC-1␣ siRNA transfection would result in decreased levels of nuclear-encoded proteins important for mitochondrial biogenesis. Downstream targets of transcription factors that PGC-1␣ is known to coactivate were reduced significantly in response to PGC-1␣ knockdown. Tfam (Fig. 3A) and COX-IV (Fig. 3B ) protein content were decreased by 40 and 50%, respectively, on days 7 and 9 of differentiation in PGC-1␣ siRNA-transfected myotubes (P Ͻ 0.05). In contrast, protein levels of mtHSP70 remained unchanged in PGC-1␣-deficient muscle cells (Fig. 3C) .
Effect of CCA on PGC-1␣ expression in siRNA-transfected cells. Muscle cells transfected with PGC-1␣ siRNA were subjected to CCA and evaluated for alterations in the mRNA and protein expression of PGC-1␣ as well as the transcript levels of coregulatory proteins involved in maintenance of mitochondrial content. As expected, siRNA transfection significantly reduced PGC-1␣ protein (P Ͻ 0.05; Fig. 4A ) by ϳ50%. The specificity of the PGC-1␣ antibody used for these measurements is demonstrated in Fig. 4B with the use of a PGC-1␣-HA tag adenoviral overexpression system in C 2 C 12 myotubes. Transfection of PGC-1␣ siRNA in myotubes concurrently infected with the PGC-1␣-encoding adenovirus revealed a significant reduction in PGC-1␣ protein when probed with either the HA tag antibody or the PGC-1␣ antibody (Fig.  4B) . In response to 4 days of contractile activity, protein expression of the coactivator was increased in scramble-transfected cells. PGC-1␣ levels also increased in siRNA-transfected cells to a level that was similar to that found in nonstimulated cells, although it remained significantly depressed relative to the control CCA condition (Fig. 4A) . Alterations in steady-state PGC-1␣ mRNA paralleled the changes in PGC-1␣ protein (Fig. 4C) . Interestingly, the expression of PGC-1␤, PRC, and RIP140 was unchanged under all conditions of PGC-1␣ knockdown and CCA (Fig. 4D) .
Alterations in the expression of NUGEMPs as a result of CCA in PGC-1␣-depleted cells. Various nuclear-encoded mitochondrial proteins were examined to assess the importance of PGC-1␣ on their expression with contractile activity. The protein content of Tfam (Fig. 5A ) and cytochrome c (Fig. 5B) was significantly reduced by 40% in siRNA-transfected muscle cells. Contractile activity increased the expression of both proteins, as expected. However, knockdown of PGC-1␣ did not impede the CCA-induced increases in Tfam and cytochrome c (Fig. 5, A and B) . Contrary to these findings, COX-IV protein levels also increased with contractile activity in PGC-1␣-deficient muscle cells to a level that was similar to that found in nonstimulated cells. However, it remained significantly lower than control cells subjected to CCA (P Ͻ 0.05; Fig. 5C ).
CCA-induced mitochondrial adaptations with PGC-1␣ knockdown. COX activity was measured in muscle cells as an indicator of mitochondrial content. Knockdown of PGC-1␣ significantly reduced basal COX activity by 30% and also attenuated CCA-evoked mitochondrial biogenesis (P Ͻ 0.05; Fig. 6A ). We also examined the relationship between PGC-1␣ expression and COX activity. Our results reveal that CCAinduced changes in COX activity appear to depend on parallel changes in PGC-1␣ protein (Fig. 6B ) and mRNA (data not shown). Representative images of myotubes stained with Mitotracker Green FM also suggested decreased mitochondrial content in cells with reduced levels of PGC-1␣ (Fig. 6C) . Myotubes subjected to 4 days of contractile activity displayed an increase in fluorescence, which was reduced in PGC-1␣ knockdown cells (Fig. 6C) , suggestive of alterations in mitochondrial content.
Expression of mtDNA and TFB1M as a result of CCA in PGC-1␣-depleted cells. COX subunit I (COX-I) is one of three subunits that comprise the catalytic core of the COX complex and is encoded by mtDNA. Thus, we examined the expression of COX-I as a marker of mtDNA expression. Surprisingly, COX-I mRNA was unchanged in PGC-1␣ siRNA-transfected myotubes; however, it was increased significantly in response to contractile activity (P Ͻ 0.05; Fig. 7A ). TFB1M, a mitochondrial-specific transcription factor that binds and activates Tfam, was unaltered in cells with reduced PGC-1␣ levels (Fig.  7B) . Its protein expression was increased by ϳ50% in both scramble-and siRNA-treated myotubes subjected to CCA.
Expression of transcription factors important for the expression of NUGEMPs.
Established transcription factors that interact specifically with PGC-1␣ in the regulation of metabolism were examined to ascertain any compensatory alterations in the absence of the coactivator. The mRNA expression of NRF-1, NRF-2, and ERR␣ did not change in response to PGC-1␣ knockdown (Figs. 8, A-C) . Both NRF-1 and ERR␣ were increased as a result of CCA (P Ͻ 0.05; Fig. 8, A and C) , whereas NRF-2 levels remained constant in both scramble-and siRNA-transfected myotubes subjected to CCA (Fig. 8B) .
Activation of signaling kinases. AMPK and p38 mitogenactivated protein kinase (MAPK) are both well-recognized kinases that influence PGC-1␣ expression and mitochondrial content (21, 34) . Depletion of PGC-1␣ resulted in an increase in the activation of AMPK (P Ͻ 0.05; Fig. 9A ), which was paralleled by the augmented phosphorylation of its downstream target ACC (Fig. 9B) . There was no effect of PGC-1␣ depletion on the phosphorylation of p38. In response to CCA, the phosphorylation of both AMPK and p38 was increased approximately twofold. However, the extent of this increase siRNA, 0.088 Ϯ 0.004 pmol/g protein) and CCA (0.225 Ϯ 0.024 pmol/g protein; siRNA, 0.151 Ϯ 0.017 pmol/g proten) conditions.
DISCUSSION
It has long been established that chronic contractile activity elicits metabolic changes in skeletal muscle via mitochondrial biogenesis (14) . Although PGC-1␣ is a critical regulator of steady-state mitochondrial content and/or function in skeletal muscle, the essentiality of this protein for CCA-induced mitochondrial adaptations remains controversial. Research from our laboratory and others has implicated a role for PGC-1␣ in the mediation of organelle biogenesis in response to contractile activity (2, 6, 13, 17) . Recent work using muscle-specific PGC-1␣-KO mice has suggested a necessary role for PGC-1␣ in the exercise-evoked changes of specific mitochondrial proteins (10) . The data in the present study corroborate these findings and indicate that PGC-1␣ is required for some but not all of the normal mitochondrial adaptations that occur with contractile activity. Our data further suggest that parallel pathways, possibly involving AMPK activation but not other PGC-1 family members, could be active in mediating the full pattern of protein expression, leading to a functional organelle.
Since its discovery, considerable research has focused on the importance of PGC-1␣ in mediating changes in mitochondrial content and function (1, 36, 42) . Our previous work has shown that several markers of organelle biogenesis are significantly suppressed in muscle from PGC-1␣-KO animals (1). The present study also confirms these findings. COX activity, a reputable marker of mitochondrial content, was diminished in C 2 C 12 cells with reduced levels of the coactivator. This was also corroborated by the Mitotracker Green FM staining, since mitochondrial content was visibly decreased in PGC-1␣-deficient myotubes. Knockdown of PGC-1␣ in skeletal muscle cells also significantly reduced the expression of Tfam and COX-IV, proteins important for mtDNA expression and electron transport chain function, respectively (16) . Surprisingly, the expression of mtHSP70, a protein involved in the mitochondrial protein import machinery, was unaffected by reduced levels of the coactivator, suggesting that mtHSP70 protein expression is independent of PGC-1␣. This highlights the fact that, although PGC-1␣ is imperative for the normal expression of numerous mitochondrial proteins, the coactivator is only one of several nuclear factors that regulate proteins involved in the maintenance of mitochondrial content. Thus, we sought to examine the expression of alternative coregulatory factors that might account for compensatory alterations in PGC-1␣-depleted cells. Our findings suggest that the PGC-1 family of coactivators PGC-1␤ and PRC remain unchanged in the absence of PGC-1␣. This coincides with previous findings observed in tissues from animals lacking PGC-1␣ (13, 27) . The transcriptional corepressor RIP140 has also been implicated in the regulation of mitochondrial content. Since RIP140 functions antagonistically to PGC-1␣, we surmised that the corepressor may decrease in response to reduced levels of the coactivator. However, we failed to document a change in RIP140 expression in siRNA-transfected cells. Thus, our data suggest that related coregulatory proteins do not appear to compensate, at least at the mRNA level within the time frame of our experiments, in response to diminished levels of PGC-1␣. The data also illustrate that, unlike the changes in the expression of known PGC-1␣ downstream targets, these coregulatory proteins are unlikely to be regulated by PGC-1␣-mediated mechanisms.
Considerable research exists to suggest that PGC-1␣ may be linked to the increases in mitochondrial content observed in response to CCA. We and others have shown that PGC-1␣ is concomitantly upregulated with genes encoded by both the nuclear and mitochondrial genomes involved in mitochondrial biogenesis (2, 4, 12, 17, 32) . Our present data also demonstrate a concurrent induction of mitochondrial biogenesis and PGC-1␣ expression. Various markers of mitochondrial content, such as COX activity, respiration, and the expression of NUGEMPs, were all significantly increased in response to 4 days of CCA along with increases in PGC-1␣ expression. However, to infer that PGC-1␣ mediates these CCA-induced mitochondrial adaptations, we measured several indicators of mitochondrial content from PGC-1␣-deficient myotubes subjected to contractile activity. The markers that we chose include both NRF-1 and -2 downstream targets, because these have emerged as primary nuclear transcription factors that are coactivated by PGC-1␣ and that govern the expression of multiple nuclear genes encoding mitochondrial proteins (24) . Our results indicate that although PGC-1␣ is important for the steady-state expression of many mitochondrial proteins, such as cytochrome c and COX-IV, the coactivator influences the expression of NUGEMPs differently in response to contractile activity, in a manner that is not specific to the downstream targets of NRF-1 or -2. For example, we found that reduced levels of PGC-1␣ led to decrements of both Tfam and cytochrome c in control cells but did not attenuate increases in these proteins induced by CCA. This suggests that either 1) alternative parallel pathways exist or 2) heightened activation of the coactivator is required to support the normal CCA-induced increase in these proteins. In contrast, whereas COX-IV expression was also reduced by PGC-1␣ depletion in control cells, CCA was unable to achieve the increased expression of COX-IV normally evident. This indicates that the normal elevated expression of COX-IV relies more heavily on increased PGC-1␣ levels and that alterative compensatory pathways that might mediate an increase in COX-IV do not exist.
Based on the changes evident in both COX activity as well as fluorescence microscopy, our findings suggest that, to observe the full extent of mitochondrial biogenesis, a normal induction of PGC-1␣ beyond that found in control nonstimulated muscle cells is required. This is evident from our data, which depicts the relationship between PGC-1␣ protein content and COX activity. The increase of mitochondrial content in response to CCA in PGC-1␣-deficient myotubes indicates that the reduced amount and/or activity of PGC-1␣ is sufficient for some degree of mitochondrial biogenesis to occur. An alternative explanation is that levels of the coactivator are inadequate but that other proteins compensate to mediate the degree of mitochondrial biogenesis observed here. However, our evidence with respect to PGC-1␤, PRC, and NRF-2 does not support this. Despite an increase in the mRNA content of NRF-1 and ERR␣ in response to contractile activity, we did not observe a compensatory increase in these transcription factors in PGC-1␣ siRNA-transfected myotubes. Others have also shown that these and several other nuclear transcription factors, such as PPAR␣, also do not appear to be altered in animals lacking PGC-1␣ (3). However, it remains possible that CCA may lead to enhanced DNA-binding activity of these transcription factors, thus serving to rescue Tfam and cytochrome c levels. Regardless of potential compensatory mechanisms, an important finding of this study is that not only is PGC-1␣ vital for the maintenance of steady-state mitochondrial content, but CCA-induced levels of the coactivator are necessary for the normal induction of mitochondrial biogenesis in response to contractile activity.
Despite decreases in mitochondrial content and Tfam levels in response to PGC-1␣ siRNA transfection, the mRNA of mitochondrially encoded COX-I subunit remained unchanged. This was surprising, since Tfam regulates the expression of mtDNA-encoded genes. Thus, we suspect that the remaining levels of Tfam and/or the absence of any changes in TFB1M protein in PGC-1␣ siRNA-transfected cells may be sufficient to promote adequate transcription of mtDNA in quiescent muscle. Furthermore, we suspect that this may form part of a nuclear-to-mitochondrial signaling pathway that adjusts for the deficits of nuclear-encoded mitochondrial proteins as a result of decreased PGC-1␣ levels.
Although it is likely that the normal increase in mitochondrial content due to CCA requires PGC-1␣, this is not the case for individual nuclear-encoded mitochondrial proteins. The divergent response of selected proteins might be expected based on the fact that some gene products are PGC-1␣ dependent, whereas others are not. It is also likely that the increase in mitochondria that occurs with PGC-1␣ deficiency has an altered protein stoichiometry. Whether this is reflected functionally in terms of oxygen consumption and reactive oxygen species production has yet to be determined. The individual changes in specific proteins may also be related to the underlying function of the proteins in question. For example, Tfam is essential for the maintenance and stabilization of the mitochondrial genome (25, 38) . Studies have indicated that mtDNA copy number is directly proportional to Tfam protein levels, which suggests that Tfam may be a limiting factor for mtDNA content (8, 23) . Similarly, cytochrome c is also critical for normal mitochondrial function (15, 38) . Animals devoid of cytochrome c are unable to survive past midgestation, and cells derived from these embryos display severe defects in oxidative phosphorylation (28) . In contrast, COX-IV is one of 13 subunits that comprise complex IV, and although the subunit is important for the assembly and function of the complex, it has been reported that normal functioning of the complex can be maintained at a threshold of 40% of total COX-IV (29) . Thus, we hypothesize that multiple alternative pathways activated by contractile activity may operate to safeguard the expression of certain indispensible downstream targets of PGC-1␣ in response to CCA.
Contractile activity is also a well-known stimulus for kinase activation, such as AMPK and p38 MAPK. Chronic activation of these kinases can result in mitochondrial biogenesis. This most likely occurs via the ability of both AMPK and p38 to phosphorylate nuclear regulatory proteins that have important roles in the transcriptional activity of NUGEMPs, such as NRF-1 and PGC-1␣ (2, 5, 21, 41) . Thus, we evaluated the expression of phosphorylated AMPK and p38. Phosphorylation of both kinases was augmented in response to CCA; however, reduced expression of PGC-1␣ significantly enhanced both basal and CCA-induced phosphorylation of AMPK. This indicates that the depletion of PGC-1␣ alters processes within the cell that modulate AMPK activity. A logical explanation for this might lie in the fact that mitochondrial content is decreased, thereby reducing the ATP/ADP ratio. Our data indicate that ATP is decreased in cells with reduced PGC-1␣, which likely results in the allosteric activation of AMPK via increased AMP. This effect would be exaggerated during contractile activity in which ATP utilization is enhanced. Thus, our data provide evidence for a potential signaling mechanism involved in the compensatory response to reduced levels of PGC-1␣. The consequence of this elevated AMPK activation may serve a negative feedback role by stimulating the transcription (20) and activation of preexisting PGC-1␣. In and of itself, this compensatory mechanism could potentially account for the maintained expression of PGC-1␣ and its downstream targets (e.g., cytochrome c and Tfam) in response to CCA, even in the face of reduced PGC-1␣ expression. Experiments in which the activity of AMPK is inhibited during PGC-1␣ depletion are required to verify this.
Collectively, our data provide novel insights into the role of PGC-1␣ in contractile activity-induced mitochondrial adaptations. Our findings suggest that PGC-1␣ is necessary for the typical changes in mitochondrial proteins and organelle content that are induced by CCA. However, it is likely that the activation of multiple overlapping signaling pathways is required to observe the complete expression of NUGEMPs in response to contractile activity.
